Back to 
Centiva Capital, LP
Centiva Capital, LP
ABCL
5 quarters
Position history for Centiva Capital, LP's holdings in AbCellera Biologics Inc.
No. Centiva Capital exited its ABCL (AbCellera Biologics) position in Q2 2025. Its Q1 2025 13F listed 46,621 shares worth $103,965. Centiva Capital first reported ABCL in Q1 2021 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$535,000
Total Shares Change
-15,755
Quarter-by-Quarter History
Other major holders of ABCL: Viking Global Investors LP, Baker Bros. Advisors LP, Capital World Investors